Literature DB >> 7751577

The nomenclature of chronic hepatitis: time for a change.

P J Scheuer.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7751577     DOI： 10.1016/0168-8278(95)80269-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  15 in total

1.  sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association with Response to Antiviral Therapy.

Authors:  Michal Kukla; Krystyna Zwirska-Korczala; Andrzej Gabriel; Ewa Janczewska-Kazek; Agnieszka Berdowska; Andrzej Wiczkowski; Barbara Rybus-Kalinowska; Mariusz Kalinowski; Adam Ziolkowski; Elzbieta Wozniak-Grygiel; Marek Waluga; Blazej Nowak
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

2.  Value of liver biopsy prior to interferon therapy for chronic viral hepatitis.

Authors:  T Heintges; L Mohr; F Hensel; W Petry; F Borchard; D Häussinger; C Niederau
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

3.  Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat.

Authors:  Meng Fang; Sylviane Dewaele; Yun-Peng Zhao; Peter Stärkel; Valerie Vanhooren; Yue-Ming Chen; Xin Ji; Ming Luo; Bao-Mu Sun; Yves Horsmans; Anne Dell; Stuart M Haslam; Paola Grassi; Claude Libert; Chun-Fang Gao; Cuiying Chitty Chen
Journal:  Mol Cancer       Date:  2010-08-12       Impact factor: 27.401

Review 4.  Liver pathology of hepatitis C, beyond grading and staging of the disease.

Authors:  Sadhna Dhingra; Stephen C Ward; Swan N Thung
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

5.  Circulating microRNAs as a Fingerprint for Liver Cirrhosis.

Authors:  Yan-Jie Chen; Ji-Min Zhu; Hao Wu; Jia Fan; Jian Zhou; Jie Hu; Qian Yu; Tao-Tao Liu; Lei Yang; Chun-Lei Wu; Xiao-Ling Guo; Xiao-Wu Huang; Xi-Zhong Shen
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

6.  Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.

Authors:  Qingqing Zhang; Mingyi Xu; Ying Qu; Zhenghong Li; Qidi Zhang; Xiaobo Cai; Lungen Lu
Journal:  Mol Med Rep       Date:  2015-08-12       Impact factor: 2.952

7.  Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.

Authors:  Santiago Marfà; Gonzalo Crespo; Vedrana Reichenbach; Xavier Forns; Gregori Casals; Manuel Morales-Ruiz; Miquel Navasa; Wladimiro Jiménez
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

8.  Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis C.

Authors:  Michał Kukla; Brygida Adamek; Marek Waluga; Marzena Zalewska-Ziob; Janusz Kasperczyk; Andrzej Gabriel; Włodzimierz Mazur; Barbara Sobala-Szczygieł; Rafał J Bułdak; Wojciech Zajęcki; Lucjan Kępa; Katarzyna Ziora; Krystyna Żwirska-Korczala; Andrzej Wiczkowski; Marek Hartleb
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

9.  Serum dihydroxyacetone kinase peptide m/z 520.3 as predictor of disease severity in patients with compensated chronic hepatitis B.

Authors:  Ming-Yi Xu; Xiao-Fang Jia; Ying Qu; Rui-Dan Zheng; Zheng-Hong Yuan; Hong-Lei Weng; Steven Dooley; Xing-Peng Wang; Li-Jun Zhang; Lun-Gen Lu
Journal:  J Transl Med       Date:  2013-09-27       Impact factor: 5.531

10.  β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation.

Authors:  Wen-Song Ge; Yao-Jun Wang; Jian-Xin Wu; Jian-Gao Fan; Ying-Wei Chen; Liang Zhu
Journal:  Mol Med Rep       Date:  2014-04-01       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.